Impact of Octacalcium Phosphate/Gelatin (OCP/Gel) Composite on Bone Repair in Refractory Bone Defects.


Journal

The Tohoku journal of experimental medicine
ISSN: 1349-3329
Titre abrégé: Tohoku J Exp Med
Pays: Japan
ID NLM: 0417355

Informations de publication

Date de publication:
14 Jul 2023
Historique:
medline: 19 7 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

In clinical settings, bone grafting is frequently used to treat bone defects. Therefore, the development of bone graft substitutes with superior bone formation ability is expected, instead of autogenous bone grafting. Octacalcium phosphate (OCP) has been developed as a bone graft substitute, and preclinical studies using OCP have reported superior bone formation ability compared with β-tricalcium phosphate. Furthermore, OCP has been used in composite forms with natural polymers such as collagen and gelatin to improve the usability of OCP, and OCP/collagen composite forms have been clinically applied in the dental field because of their excellent usability and osteogenic potential. This review describes the development and preclinical results of OCP and OCP/gelatin (OCP/Gel) composites and prospects for future applications in orthopedics. The development of bone graft substitutes that achieve a high degree of biodegradability and strength will be needed for the clinical application of OCP composites in orthopedics in the future.

Identifiants

pubmed: 37197945
doi: 10.1620/tjem.2023.J040
doi:

Substances chimiques

octacalcium phosphate 13767-12-9
Gelatin 9000-70-8
Calcium Phosphates 0
Collagen 9007-34-5
Bone Substitutes 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-252

Auteurs

Yu Mori (Y)

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine.

Ryo Hamai (R)

Division of Craniofacial Function Engineering, Tohoku University Graduate School of Dentistry.

Toshimi Aizawa (T)

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine.

Osamu Suzuki (O)

Division of Craniofacial Function Engineering, Tohoku University Graduate School of Dentistry.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH